|Traded as||LSE: UDG|
|Peter Gray, Chairman|
Brendan McAtamney, CEO
|Revenue||€1,315.2 million (2018)|
|€114.1 million (2018)|
|€3.9 million (2018)|
Number of employees
UDG Healthcare plc, formerly United Drug, is a Dublin-based international company and partner to the healthcare industry, providing clinical, commercial, communication and packaging services. It is listed on the London Stock Exchange. It is a constituent of the FTSE 250 Index.
The company was established in Ballina in County Mayo as The United Drug Chemical Company, a co-operative controlled by Irish pharmacists, in 1948. UDG bought Leicestershire-based Ashfield commercial and medical services for £12 million in 2000: Ashfield, a contract sales outsourcing firm serving pharmaceutical companies, had 400 employees at the time it was acquired.
In January 2007, the company acquired Presearch, a UK laboratory services company, for GBP £2.9 million. It acquired Pharmexx, a Frankfurt-based business, in July 2012. In September 2012 it decided to move its primary listing from Irish Stock Exchange to the London Stock Exchange. It changed its name from United Drug to UDG Healthcare in October 2013. In February 2014, the company made its largest acquisition when it bought KnowledgePoint360 which specializes in healthcare communications for €105 million and made it part of its Ashfield division.
In September 2015, UDG Healthcare sold its Irish drug distribution businesses to McKesson Corporation for $466 million. In May 2016 UDG Healthcare acquired Pegasus, an integrated healthcare communications consultancy. In October 2016 the company acquired STEM Marketing, a provider of commercial, marketing and medical audits to pharmaceutical companies. In July 2017, the company acquired Vynamic; later in the same month it acquired Cambridge BioMarketing for up to $35 million.. In August 2018, UDG Healthcare announced the sale of its Aquilant division to H2 Equity Partners, a European private equity firm, for a total potential net consideration of up to €23 million (approximately $27 million). 
UDG Healthcare plc operates across two divisions: Ashfield and Sharp.
- Michael Cogley (3 February 2016). "UDG boss Fitzgerald steps down from €2.5m-a-year role". Independent.ie. Retrieved 2016-07-31.
- "Annual Report 2018". UDG Healthcare. Retrieved 20 March 2019.
- "At a glance". UDG Healthcare. Retrieved 20 March 2019.
- "B2B Database with Highly Accurate & Detailed Profiles - ZoomInfo". zoominfo.com. Retrieved 3 April 2015.
- Irish buyer for Ashfield, This is Money (Daily Mail), May 7, 2000.
- "United Drug buy UK lab distributor for £2.9m". RTÉ News. January 26, 2007.
- United Drug snaps up Pharmexx Irish Times, 26 July 2012
- United Drug set to shift to LSE FT, 5 September 2012
- United Drug: Yes to name change Irish Examiner, 10 August 2013
- UPDATE 2-UDG raises earnings growth forecast, sees deal paying off, Reuters.com (14 May 2014)
- UDG Healthcare invests €105m to expand communications unit The Irish Times, 27 February 2014
- Roshni Menon (18 September 2015). "UDG Healthcare to sell two units to McKesson for $466 million". Reuters.com. Retrieved 2016-07-31.
- "Healthcare Group UDG buys UK's second largest PR firm Pegasus for £16.8 million". 19 May 2016. Retrieved 28 April 2017.
- "UDG Healthcare acquires STEM Marketing for £84m". PM Live. 21 October 2016. Retrieved 28 April 2017.
- "Rare disease agency Cambridge Bio goes global with $35M buyout by Irish UDG - FiercePharma". www.FiercePharma.com. Retrieved 22 January 2018.
- "UDG Healthcare sells non-core Aquilant division and reviews Ashfield business". 8 August 2018. Retrieved 14 November 2018.
- "Sharp Packaging Services, a division of UDG Healthcare plc, announces capacity expansion in the US and UK". FT. 3 April 2017. Retrieved 28 April 2017.
|This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.|